Evercore ISI Issues Positive Forecast for Privia Health Group (NASDAQ:PRVA) Stock Price

Privia Health Group (NASDAQ:PRVA) had its price target hoisted by analysts at Evercore ISI from $28.00 to $30.00 in a report released on Friday,Benzinga reports. The firm presently has an “outperform” rating on the stock. Evercore ISI’s price target would indicate a potential upside of 27.01% from the stock’s current price.

Other equities research analysts have also issued research reports about the company. Citizens Jmp upped their target price on Privia Health Group from $30.00 to $31.00 and gave the company a “market outperform” rating in a research report on Friday. Piper Sandler dropped their price target on Privia Health Group from $36.00 to $35.00 and set an “overweight” rating on the stock in a research note on Monday, August 11th. JMP Securities raised their price objective on shares of Privia Health Group from $29.00 to $30.00 and gave the stock a “market outperform” rating in a research report on Friday, August 29th. Weiss Ratings reiterated a “sell (d+)” rating on shares of Privia Health Group in a research note on Wednesday, October 8th. Finally, Barclays boosted their target price on shares of Privia Health Group from $21.00 to $22.00 and gave the company an “equal weight” rating in a research report on Thursday, October 9th. Twelve equities research analysts have rated the stock with a Buy rating, two have issued a Hold rating and one has assigned a Sell rating to the stock. According to MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and an average target price of $29.25.

Privia Health Group Price Performance

Shares of PRVA traded down $0.36 during trading hours on Friday, hitting $23.62. 431,479 shares of the stock were exchanged, compared to its average volume of 843,592. Privia Health Group has a fifty-two week low of $18.77 and a fifty-two week high of $26.51. The business has a 50-day moving average of $24.14 and a 200-day moving average of $22.76. The firm has a market capitalization of $2.90 billion, a P/E ratio of 214.33, a price-to-earnings-growth ratio of 3.41 and a beta of 0.83.

Privia Health Group (NASDAQ:PRVA) last released its earnings results on Tuesday, June 7th. The company reported $0.10 earnings per share (EPS) for the quarter. Privia Health Group had a net margin of 0.78% and a return on equity of 2.13%. The business had revenue of $213.61 million for the quarter. As a group, analysts forecast that Privia Health Group will post 0.14 earnings per share for the current fiscal year.

Institutional Inflows and Outflows

A number of large investors have recently made changes to their positions in the business. US Bancorp DE increased its position in shares of Privia Health Group by 2.4% during the first quarter. US Bancorp DE now owns 18,487 shares of the company’s stock worth $415,000 after acquiring an additional 429 shares in the last quarter. Arizona State Retirement System lifted its holdings in shares of Privia Health Group by 1.9% in the third quarter. Arizona State Retirement System now owns 28,835 shares of the company’s stock valued at $718,000 after purchasing an additional 524 shares in the last quarter. Bank of Montreal Can lifted its holdings in shares of Privia Health Group by 1.9% in the second quarter. Bank of Montreal Can now owns 28,694 shares of the company’s stock valued at $660,000 after purchasing an additional 543 shares in the last quarter. Illinois Municipal Retirement Fund grew its holdings in Privia Health Group by 1.1% during the third quarter. Illinois Municipal Retirement Fund now owns 55,501 shares of the company’s stock worth $1,382,000 after buying an additional 585 shares in the last quarter. Finally, CWM LLC raised its position in Privia Health Group by 50.3% in the 1st quarter. CWM LLC now owns 1,804 shares of the company’s stock valued at $40,000 after buying an additional 604 shares during the last quarter. 94.48% of the stock is owned by institutional investors.

About Privia Health Group

Privia Health Group, Inc operates as a national physician-enablement company in the United States. The company collaborates with medical groups, health plans, and health systems to optimize physician practices, enhance patient experiences, and reward doctors for delivering care in-person and virtual settings.